Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-FR Version v23-FR
Language French French
Date Updated 2023-04-14 2023-04-14
Drug Identification Number 02401967 02401967
Brand name TRI-CIRA LO 21 TRI-CIRA LO 21
Common or Proper name TRICIRALO TRICIRALO
Company Name APOTEX INC APOTEX INC
Ingredients ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE ETHINYL ESTRADIOL NORGESTIMATE
Strength(s) 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 21 21
ATC code G03AB G03AB
ATC description
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-10-26 2022-10-26
Estimated end date 2023-04-21 2023-04-21
Actual end date 2023-04-13 2023-04-13
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments 28 pack format is available 28 pack format is available
Health Canada comments